Pages that link to "Q41593344"
Jump to navigation
Jump to search
The following pages link to Robert Weinkove (Q41593344):
Displayed 47 items.
- Non-Invasive Detection of Anaemia Using Digital Photographs of the Conjunctiva (Q33448177) (← links)
- Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease. (Q34437054) (← links)
- Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy (Q36862410) (← links)
- Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014. (Q38284455) (← links)
- NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity (Q38412832) (← links)
- An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment (Q38418658) (← links)
- Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials (Q38674818) (← links)
- Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination (Q39049093) (← links)
- Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma. (Q39245543) (← links)
- Temporal changes in neutropenic blood culture isolates and disease associations: a single centre series of 1139 episodes (Q40044379) (← links)
- Association between early peak temperature and mortality in neutropenic sepsis (Q40177550) (← links)
- Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults. (Q40243248) (← links)
- Fever and pancytopenia in a patient with Crohn's disease (Q40272079) (← links)
- An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemia. (Q41593302) (← links)
- Venetoclax and obinutuzumab in chronic lymphocytic leukemia (Q42348732) (← links)
- Low-dose thalidomide in myelofibrosis (Q46570726) (← links)
- Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins (Q47144502) (← links)
- Franca Ronchese (Q47524296) (← links)
- Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy. (Q50750469) (← links)
- A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. (Q52822549) (← links)
- Immunity without innate lymphoid cells. (Q53083114) (← links)
- Efficient depletion of chronic lymphocytic leukemia B cells using serial rounds of immunomagnetic depletion. (Q53102811) (← links)
- Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact? (Q57090569) (← links)
- Ian F Hermans (Q57555897) (← links)
- Flow Cytometric Analysis of Mechanically Disaggregated Bone Marrow Trephine Biopsies (Q57802283) (← links)
- Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey (Q60213136) (← links)
- Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist (Q62229495) (← links)
- Species-Specific Activity of Glycolipid Ligands for Invariant NKT Cells (Q62230696) (← links)
- Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations (Q64057605) (← links)
- Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients. (Q64980399) (← links)
- Fibrinogen concentrate for acquired hypofibrinogenaemic states (Q81572914) (← links)
- Chimeric antigen receptor T-cell therapies: Optimising the dose (Q90349845) (← links)
- Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies (Q90647204) (← links)
- A randomized controlled feasibility trial of paracetamol during febrile neutropenia in hemato-oncology patients (Q91106466) (← links)
- Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions (Q92539522) (← links)
- B-cell prolymphocytic leukaemia with a t(4;14) FGFR3/IGH translocation: response to ibrutinib (Q94460763) (← links)
- Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance (Q94654860) (← links)
- Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic (Q94949799) (← links)
- IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells (Q101476400) (← links)
- Olivia K Burn (Q104560092) (← links)
- Augmenting anti-tumour T cell responses using innate-like T cell ligands (Q111965931) (← links)
- Invariant Natural Killer T Cells in Chronic Lymphocytic Leukaemia (Q112465772) (← links)
- Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy (Q112576605) (← links)
- John Manley Carter (Q112665509) (← links)
- Serum biomarkers and paracetamol during post-chemotherapy infections (Q112908218) (← links)
- Investigation of Mitochondrial Transfer between Human Erythroblasts (Q112949211) (← links)
- A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma (Q112952093) (← links)